Work

A phase I/II study of bexarotene (B) and erlotinib (E): A novel targeted combination therapy for lung cancer and other aerodigestive tract (ADT) tumors

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.3092

Authors: K. H. Dragnev, W. J. Petty, V. Memoli, W. Black, I. Williams, J. R. Rigas, E. Dmitrovsky

Institution: Dartmouth–Hitchcock Medical Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2267387685

Cites:

Cited by: 2

Related to: 10